Post-transplant diabetes mellitus (PTDM) is a frequent consequence of solid organ
transplantation. PTDM has been associated with greater mortality and increased infections …

Background: Death with graft function remains an important cause of graft loss among
kidney transplant recipients (KTRs). Little is known about the trend of specific causes of …

The causes of kidney allograft loss remain unclear. Herein we investigated these causes in
1317 conventional kidney recipients. The cause of graft loss was determined by reviewing …

Mammalian target of rapamycin (mTOR) inhibitors are used as potent immunosuppressive
agents in solid-organ transplant recipients (everolimus and sirolimus) and as antineoplastic …

New-onset diabetes mellitus after transplantation (NODAT) is a frequent complication in
kidney allograft recipients. It may be caused by modifiable and non-modifiable factors. The …

Diabetes mellitus is becoming increasingly prevalent and is considered a rapidly growing
concern for healthcare systems. Besides the cardiovascular complications, diabetes mellitus …

Despite substantial improvement in short-term results after kidney transplantation, increases
in long-term graft survival have been modest. A significant impediment has been the …

Several recent randomized controlled trials (RCTs) have demonstrated the wide clinical
application of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in improving kidney and …

Objective. To analyze the risk factors for new-onset diabetes mellitus (NODM) in liver
transplant recipients using the Organ Procurement and Transplant Network/United Network …

Fertility rates, pregnancy, and maternal outcomes are not well described among women with
a functioning kidney transplant. Using data from the Australian and New Zealand Dialysis …